Dimensional Fund Advisors’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding NMRA
SL
Dimensional Fund Advisors's NMRA Position: Q3 2026 in Review
Dimensional Fund Advisors reduced its Neumora Therapeutics (NMRA) stake by 3.5% in Q3 2026, selling an estimated $28.1K and leaving 557,334 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #2994.
Dimensional Fund Advisors first reported a position in NMRA in Q1 2025 and has held it in 7 quarters since. The position peaked at $982K in Q2 2026. 90 funds tracked by Wall St. Rank hold NMRA as of Q3 2026.
- Dimensional Fund Advisors held 557,334 shares of Neumora Therapeutics worth $333K as of Q3 2026.
- Dimensional Fund Advisors sold 20,281 Neumora Therapeutics shares in Q3 2026, an estimated $28.1K.
- Neumora Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2994 holding.
- Dimensional Fund Advisors first reported a position in Neumora Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Dimensional Fund Advisors's Neumora Therapeutics position peaked at $982K in Q2 2026.
- 90 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.